TrialCardiovascular diabetology2023

Combination of exercise and GLP-1 receptor agonist treatment reduces severity of metabolic syndrome, abdominal obesity, and inflammation: a randomized controlled trial.

Rasmus M Sandsdal et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.